Lv3
218 积分 2024-03-05 加入
177Lu-labeled antibody-drug conjugate: a dual mechanistic treatment modality in solid tumors
1天前
待确认
Development of a Tumor-Specific Multivalent CD40 Agonist Antibody FAPxCD40 for Cancer Therapy: Balancing Efficacy and Toxicity
1天前
已完结
PF-08046032: A novel, investigational CD25-directed antibody-drug conjugate optimized for selective depletion of regulatory T cells in advanced malignant tumors
1天前
已完结
From Efficiency to Yield: Exploring Recent Advances in CHO Cell Line Development for Monoclonal Antibodies
28天前
已完结
Design, Synthesis, In Vitro and In Vivo Evaluation of Cereblon Binding Bruton’s Tyrosine Kinase (BTK) Degrader CD79b targeted Antibody Drug Conjugates
1个月前
已完结
PROTAC targeted protein degraders: the past is prologue
1个月前
已完结
Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion
2个月前
已完结
A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer’s disease
2个月前
已完结
Rapid identification of reactive cysteine residues for site-specific labeling of antibody-Fabs
3个月前
已完结
A High Performing Tool for Residue Solvent Accessibility Prediction
3个月前
已完结
皖公网安备34019202002308
